HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Ming Lin Selected Research

Lutein

3/2015Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
1/2015Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration.
2/2014Effects of lutein and lycopene on carotid intima-media thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial.
2/2013Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration.
1/2013Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population.
11/2012Serum carotenoids in relation to risk factors for development of atherosclerosis.
11/2012Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
10/2012Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
2/2012Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.
1/2010Effects of lutein and zeaxanthin on aspects of eye health.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Ming Lin Research Topics

Disease

7Macular Degeneration (Age-Related Maculopathy)
03/2015 - 01/2010
3Atherosclerosis
02/2014 - 11/2012
3Iron Deficiencies
11/2008 - 09/2004
1Diabetes Mellitus
05/2017
1Endocrine System Diseases (Endocrine Diseases)
05/2017
1Insulin Resistance
05/2017
1Silicosis
03/2012
1Blister (Bulla)
03/2012
1Pneumothorax
03/2012
1Liver Neoplasms (Liver Cancer)
06/2010
1Eye Diseases (Eye Disease)
01/2010
1Cataract (Cataracts)
01/2010
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2010
1Bone Resorption
08/2009
1Amblyopia (Lazy Eye)
04/2009
1Anisometropia
04/2009
1Chronic Disease (Chronic Diseases)
01/2009
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
09/2004
1cyclotropia
04/2004

Drug/Important Bio-Agent (IBA)

11LuteinIBA
03/2015 - 01/2009
8ZeaxanthinsIBA
03/2015 - 01/2010
3Macular PigmentIBA
03/2015 - 11/2012
2Retinaldehyde (Retinal)IBA
03/2015 - 10/2012
2CytokinesIBA
01/2013 - 11/2012
2Transferrin Receptors (Transferrin Receptor)IBA
11/2008 - 02/2008
2IronIBA
02/2008 - 09/2004
1Insulin (Novolin)FDA Link
05/2017
1LycopeneIBA
02/2014
1Biomarkers (Surrogate Marker)IBA
02/2013
1LipidsIBA
01/2013
1Apolipoproteins E (ApoE)IBA
01/2013
1Lipoproteins (Lipoprotein)IBA
01/2013
1Carotenoids (Carotene)IBA
11/2012
1Triglycerides (Triacylglycerol)IBA
11/2012
1Polyglycolic Acid (Polyglycolide)IBA
03/2012
1Prostaglandins AIBA
03/2012
1Repair MaterialIBA
03/2012
1SoilIBA
06/2010
1ChromiumIBA
06/2010
1NickelIBA
06/2010
1Proteins (Proteins, Gene)FDA Link
08/2009
1Whey ProteinsIBA
08/2009
1(S-dinitrophenyl)-6-mercaptopurine riboside triphosphateIBA
04/2004

Therapy/Procedure

1Thoracotomy
03/2012
1Laser In Situ Keratomileusis (LASIK)
04/2009
1Contact Lenses
04/2009
1Excimer Lasers
04/2009